Allinky Biopharma

Allinky Biopharma is focused on the discovery of small molecule drugs for the treatment of chronic inflammatory conditions, age-related degenerative diseases and cancer. Based on recent advances of molecular medicine, Allinky proposes to address the treatment of these prevalent pathologies at their molecular origins; and to follow nature's strategy to control excessive activation of a given protein using a novel class of therapeutics: allosteric modulators.

Allinky has been founded by renowned scientific and clinical researchers with a personal commitment to apply their research findings at a molecular and cellular level to discover novel therapeutics. Allinky is a drug discovery company that is starting to become a well-known player in the application of molecular-based medicine to fight prevalent diseases such as Alzheimer's, ictus, rheumatoid arthritis, osteoarthritis, diabetes type II, atherosclerosis and certain types of cancer.